ArticleJournal of neurosurgery. Case lessons2025
Symptomatic cerebral hyperperfusion after occipital artery-posterior cerebral artery bypass in a patient with moyamoya disease: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMoyamoya disease (MMD) is a progressive, steno-occlusive cerebrovascular disorder. Posterior cerebral artery (PCA) stenosis can develop after successful anterior circulation revascularization. Although symptomatic cerebral hyperperfusion (CHP) is a recognized complication of anterior revascularization, it is rarely reported following occipital artery (OA)-PCA bypass. OBSERVATIONS: The authors report the case of a 50-year-old woman with MMD who developed symptomatic hemodynamic compromise due to progressive right PCA stenosis 10 years after bilateral superficial temporal artery-middle cerebral artery bypass and indirect revascularization. She underwent OA-PCA bypass with encephalo-myo-synangiosis. On postoperative day 1, single-photon emission CT revealed focal CHP in the right parietal lobe, with cerebral blood flow (CBF) increasing to 160% of preoperative levels. The patient developed a pulsatile headache and left-sided tongue numbness. By postoperative day 7, CBF had decreased to 110%, and perfusion had improved throughout the right parietal-occipital region. With strict blood pressure control and minocycline administration, both symptoms and CHP resolved. At the 1-year follow-up, the patient remained symptom free without stroke recurrence. LESSONS: Symptomatic CHP can occur after OA-PCA bypass in MMD. Perioperative CHP management, including blood pressure control and anti-inflammatory therapy, is essential for optimal outcomes of posterior circulation bypass. https://thejns.org/doi/10.3171/CASE25486.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.